CN102367291A - 含单官能团的多级支化聚乙二醇及其合成方法 - Google Patents
含单官能团的多级支化聚乙二醇及其合成方法 Download PDFInfo
- Publication number
- CN102367291A CN102367291A CN2011101059850A CN201110105985A CN102367291A CN 102367291 A CN102367291 A CN 102367291A CN 2011101059850 A CN2011101059850 A CN 2011101059850A CN 201110105985 A CN201110105985 A CN 201110105985A CN 102367291 A CN102367291 A CN 102367291A
- Authority
- CN
- China
- Prior art keywords
- polyethylene glycol
- och
- reaction
- functional group
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002202 Polyethylene glycol Substances 0.000 title claims abstract description 92
- 229920001223 polyethylene glycol Polymers 0.000 title claims abstract description 85
- 238000001308 synthesis method Methods 0.000 title abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 14
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 38
- 238000006243 chemical reaction Methods 0.000 claims description 37
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 32
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 32
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 20
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 claims description 18
- 125000000524 functional group Chemical group 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- IRAPFUAOCHNONS-UHFFFAOYSA-N potassium;phenylmethylbenzene Chemical compound [K+].C=1C=CC=CC=1[CH-]C1=CC=CC=C1 IRAPFUAOCHNONS-UHFFFAOYSA-N 0.000 claims description 13
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical class CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 claims description 12
- 239000003999 initiator Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 230000035484 reaction time Effects 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 6
- 239000005457 ice water Substances 0.000 claims description 6
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 6
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 claims description 5
- 239000007810 chemical reaction solvent Substances 0.000 claims description 5
- 229960001760 dimethyl sulfoxide Drugs 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000004440 column chromatography Methods 0.000 claims description 3
- 150000002009 diols Chemical class 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 230000002572 peristaltic effect Effects 0.000 claims description 3
- 239000012264 purified product Substances 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 description 28
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 28
- 239000003814 drug Substances 0.000 description 24
- -1 polyoxyethylene Polymers 0.000 description 23
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 13
- 238000005481 NMR spectroscopy Methods 0.000 description 13
- 229910052739 hydrogen Inorganic materials 0.000 description 13
- 239000001257 hydrogen Substances 0.000 description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 239000004698 Polyethylene Substances 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 229920000573 polyethylene Polymers 0.000 description 12
- 239000012141 concentrate Substances 0.000 description 11
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 11
- 238000001228 spectrum Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 230000008021 deposition Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000007059 acute toxicity Effects 0.000 description 6
- 231100000403 acute toxicity Toxicity 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 0 CC(C)(*(*)*)ON Chemical compound CC(C)(*(*)*)ON 0.000 description 4
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 229960004316 cisplatin Drugs 0.000 description 3
- 229920001427 mPEG Polymers 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- NMPVEAUIHMEAQP-UHFFFAOYSA-N 2-Bromoacetaldehyde Chemical compound BrCC=O NMPVEAUIHMEAQP-UHFFFAOYSA-N 0.000 description 2
- RTNUTCOTGVKVBR-UHFFFAOYSA-N 4-chlorotriazine Chemical class ClC1=CC=NN=N1 RTNUTCOTGVKVBR-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 102000006992 Interferon-alpha Human genes 0.000 description 2
- 108010047761 Interferon-alpha Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 150000001261 hydroxy acids Chemical group 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000006320 pegylation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 150000003536 tetrazoles Chemical class 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- ZJIFDEVVTPEXDL-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) hydrogen carbonate Chemical compound OC(=O)ON1C(=O)CCC1=O ZJIFDEVVTPEXDL-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- LRWZZZWJMFNZIK-UHFFFAOYSA-N 2-chloro-3-methyloxirane Chemical compound CC1OC1Cl LRWZZZWJMFNZIK-UHFFFAOYSA-N 0.000 description 1
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- XEUCQOBUZPQUMQ-UHFFFAOYSA-N Glycolone Chemical compound COC1=C(CC=C(C)C)C(=O)NC2=C1C=CC=C2OC XEUCQOBUZPQUMQ-UHFFFAOYSA-N 0.000 description 1
- UWIULCYKVGIOPW-UHFFFAOYSA-N Glycolone Natural products CCOC1=C(CC=CC)C(=O)N(C)c2c(O)cccc12 UWIULCYKVGIOPW-UHFFFAOYSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- CGIHPACLZJDCBQ-UHFFFAOYSA-N acibenzolar Chemical compound SC(=O)C1=CC=CC2=C1SN=N2 CGIHPACLZJDCBQ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- PMSGJXMYHUSZEI-UHFFFAOYSA-N butanedioic acid;pyrrolidine-2,5-dione Chemical compound O=C1CCC(=O)N1.OC(=O)CCC(O)=O PMSGJXMYHUSZEI-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- HCPOCMMGKBZWSJ-UHFFFAOYSA-N ethyl 3-hydrazinyl-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)NN HCPOCMMGKBZWSJ-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 231100000734 genotoxic potential Toxicity 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- DTPQZKZONQKKSU-UHFFFAOYSA-N silver azanide silver Chemical compound [NH2-].[Ag].[Ag].[Ag+] DTPQZKZONQKKSU-UHFFFAOYSA-N 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 230000003335 steric effect Effects 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110105985.0A CN102367291B (zh) | 2011-04-26 | 2011-04-26 | 含单官能团的多级支化聚乙二醇及其合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110105985.0A CN102367291B (zh) | 2011-04-26 | 2011-04-26 | 含单官能团的多级支化聚乙二醇及其合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102367291A true CN102367291A (zh) | 2012-03-07 |
CN102367291B CN102367291B (zh) | 2014-01-15 |
Family
ID=45759886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110105985.0A Active CN102367291B (zh) | 2011-04-26 | 2011-04-26 | 含单官能团的多级支化聚乙二醇及其合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102367291B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102898641A (zh) * | 2012-06-13 | 2013-01-30 | 厦门赛诺邦格生物科技有限公司 | 一种含单一活性官能团的y型聚乙二醇及其制备方法 |
CN103044675A (zh) * | 2013-01-17 | 2013-04-17 | 厦门赛诺邦格生物科技有限公司 | 一种单一官能化的支化聚乙二醇 |
CN103044676A (zh) * | 2013-01-17 | 2013-04-17 | 厦门赛诺邦格生物科技有限公司 | 一种聚乙二醇修饰的生物相关物质 |
WO2014059674A1 (zh) * | 2012-10-19 | 2014-04-24 | 江苏博特新材料有限公司 | 一种减水剂中间体、其制备方法及由其制备的减水剂 |
CN103881084A (zh) * | 2014-03-14 | 2014-06-25 | 厦门赛诺邦格生物科技有限公司 | 一种支化聚乙二醇的磷脂类衍生物及其组成的脂质膜结构体 |
CN104877127A (zh) * | 2015-06-23 | 2015-09-02 | 厦门赛诺邦格生物科技有限公司 | 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质 |
WO2019001473A1 (zh) * | 2017-06-28 | 2019-01-03 | 北京键凯科技股份有限公司 | 一种树状多缩乙二醇衍生物及其制备方法和应用 |
US10954346B2 (en) | 2018-12-27 | 2021-03-23 | Industrial Technology Research Institute | Resin and ink |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101724144A (zh) * | 2008-11-03 | 2010-06-09 | 北京键凯科技有限公司 | 新型的多臂聚乙二醇及其制备方法和应用 |
CN101831065A (zh) * | 2009-03-13 | 2010-09-15 | 复旦大学 | 一种含单一活性功能基团的多臂星型聚乙二醇及其制备方法 |
-
2011
- 2011-04-26 CN CN201110105985.0A patent/CN102367291B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101724144A (zh) * | 2008-11-03 | 2010-06-09 | 北京键凯科技有限公司 | 新型的多臂聚乙二醇及其制备方法和应用 |
CN101831065A (zh) * | 2009-03-13 | 2010-09-15 | 复旦大学 | 一种含单一活性功能基团的多臂星型聚乙二醇及其制备方法 |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102898641A (zh) * | 2012-06-13 | 2013-01-30 | 厦门赛诺邦格生物科技有限公司 | 一种含单一活性官能团的y型聚乙二醇及其制备方法 |
WO2014059674A1 (zh) * | 2012-10-19 | 2014-04-24 | 江苏博特新材料有限公司 | 一种减水剂中间体、其制备方法及由其制备的减水剂 |
CN103044675B (zh) * | 2013-01-17 | 2015-09-09 | 厦门赛诺邦格生物科技有限公司 | 一种单一官能化的支化聚乙二醇 |
CN103044676A (zh) * | 2013-01-17 | 2013-04-17 | 厦门赛诺邦格生物科技有限公司 | 一种聚乙二醇修饰的生物相关物质 |
CN103044675A (zh) * | 2013-01-17 | 2013-04-17 | 厦门赛诺邦格生物科技有限公司 | 一种单一官能化的支化聚乙二醇 |
CN103881084A (zh) * | 2014-03-14 | 2014-06-25 | 厦门赛诺邦格生物科技有限公司 | 一种支化聚乙二醇的磷脂类衍生物及其组成的脂质膜结构体 |
CN105622925A (zh) * | 2014-03-14 | 2016-06-01 | 厦门赛诺邦格生物科技股份有限公司 | 一种支化聚乙二醇的脂质衍生物及其组成的脂质膜结构体 |
CN105622925B (zh) * | 2014-03-14 | 2017-09-12 | 厦门赛诺邦格生物科技股份有限公司 | 一种支化聚乙二醇的脂质衍生物及其组成的脂质膜结构体 |
CN104877127A (zh) * | 2015-06-23 | 2015-09-02 | 厦门赛诺邦格生物科技有限公司 | 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质 |
CN104877127B (zh) * | 2015-06-23 | 2017-11-10 | 厦门赛诺邦格生物科技股份有限公司 | 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质 |
US10434182B2 (en) | 2015-06-23 | 2019-10-08 | Xiamen Sinopeg Biotech Co., Ltd. | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof |
US10660969B2 (en) | 2015-06-23 | 2020-05-26 | Xiamen Sinopeg Biotech Co., Ltd. | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof |
WO2019001473A1 (zh) * | 2017-06-28 | 2019-01-03 | 北京键凯科技股份有限公司 | 一种树状多缩乙二醇衍生物及其制备方法和应用 |
US10954346B2 (en) | 2018-12-27 | 2021-03-23 | Industrial Technology Research Institute | Resin and ink |
Also Published As
Publication number | Publication date |
---|---|
CN102367291B (zh) | 2014-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102367291B (zh) | 含单官能团的多级支化聚乙二醇及其合成方法 | |
CN102898641A (zh) | 一种含单一活性官能团的y型聚乙二醇及其制备方法 | |
CN103920160B (zh) | 环糊精为媒介的石墨烯/透明质酸组装体及其制备方法 | |
CN102188717B (zh) | 一种自乳化阿霉素纳米药物及其制备方法 | |
CN108752541B (zh) | 以偶氮键作连接键的具有乏氧、温度双重响应性两亲性嵌段聚合物及其制备方法 | |
CN102367290B (zh) | 链官能化的多级支化聚乙二醇及其合成方法 | |
CN109867734A (zh) | 一类咖啡酸修饰的环糊精衍生物及其制备方法 | |
CN103044676B (zh) | 一种聚乙二醇修饰的生物相关物质 | |
CN109867733A (zh) | 一类阿魏酸修饰的环糊精衍生物及其制备方法 | |
CN103159819A (zh) | 一种胆固醇衍生物的合成及其在基因转染中的应用 | |
KR20190133252A (ko) | 멀티 암 표적 항암 콘쥬게이트 | |
CN109908084A (zh) | 一种铂交联喜树碱前药胶束纳米药物及其制备方法和应用 | |
CN113264983A (zh) | 一种用于抗体偶联药物的连接子lnd1088的合成方法 | |
CN110128482B (zh) | 一种具有肿瘤靶向的新型Pt(IV)配合物的制备方法及其应用 | |
CN110279869B (zh) | 一种葡聚糖-槲皮素前药聚合物的制备方法 | |
US20190142954A1 (en) | Polymer-bonded ca4 pharmaceutical compound and preparation method therefor | |
CN1332716C (zh) | 一种高分子抗肿瘤顺铂药物及其制备方法 | |
CN113896882A (zh) | 一种聚乙二醇-乙烯基醚衍生物的合成方法 | |
CN114656453A (zh) | 七甲川吲哚花菁-tempo化学偶链小分子和制备方法及其制备辐射防护制剂的应用 | |
CN109988297B (zh) | 一种烷基化聚乙二醇化奥沙利铂前体的制备方法 | |
CN114848835B (zh) | 塞来昔布的聚乙二醇修饰及连接叶酸基团的靶向药物分子及制备方法 | |
US20200325274A1 (en) | Tertiary alkoxy polyethylene glycol and derivatives thereof | |
CN107501054A (zh) | 一种单分散聚乙二醇单甲醚的制备方法 | |
CN114685783B (zh) | 一种抗肿瘤聚氨基酸及其制备方法、应用 | |
CN103920163B (zh) | 一种紫杉醇复合物、制备方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: XIAMEN SAINUO BANGGE BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LIU CHAO Effective date: 20120220 Free format text: FORMER OWNER: WENG WENGUI Effective date: 20120220 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 363000 ZHANGZHOU, FUJIAN PROVINCE TO: 361000 XIAMEN, FUJIAN PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120220 Address after: 361000, Fujian province Xiamen torch hi tech Zone (Xiangan) Industrial Zone incubation center two construction building A block 903 and 905 room Applicant after: XIAMEN SINOPEG BIOTECH INC. Address before: 363000, building D, 15 floor, Garden Mansion, Yanan North Road, Fujian, Zhangzhou Applicant before: Liu Chao Co-applicant before: Weng Wengui |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 361000, Fujian province Xiamen torch hi tech Zone (Xiangan) Industrial Zone incubation center two construction building A block 903 and 905 room Patentee after: XIAMEN SINOPEG BIOTECHNOLOGY CO., LTD. Address before: 361000, Fujian province Xiamen torch hi tech Zone (Xiangan) Industrial Zone incubation center two construction building A block 903 and 905 room Patentee before: XIAMEN SINOPEG BIOTECH INC. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Mono-functional group-containing multilevel branched polyethylene glycol and its synthesis method Effective date of registration: 20170830 Granted publication date: 20140115 Pledgee: Industrial Bank Limited by Share Ltd Xiamen branch Pledgor: XIAMEN SINOPEG BIOTECHNOLOGY CO., LTD. Registration number: 2017350000100 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20181218 Granted publication date: 20140115 Pledgee: Industrial Bank Limited by Share Ltd Xiamen branch Pledgor: XIAMEN SINOPEG BIOTECHNOLOGY CO., LTD. Registration number: 2017350000100 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Mono-functional group-containing multilevel branched polyethylene glycol and its synthesis method Effective date of registration: 20190813 Granted publication date: 20140115 Pledgee: Xiamen finance Company limited by guarantee Pledgor: XIAMEN SINOPEG BIOTECHNOLOGY CO., LTD. Registration number: Y2019990000068 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220107 Granted publication date: 20140115 Pledgee: Xiamen finance Company limited by guarantee Pledgor: XIAMEN SINOPEG BIOTECH Co.,Ltd. Registration number: Y2019990000068 |